Acrivon Therapeutics (ACRV) Depreciation & Amortization (CF) (2021 - 2026)
Acrivon Therapeutics' Depreciation & Amortization (CF) came in at $400,000 for Q2 2026, up 33.3% from $300,000 a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
Acrivon Therapeutics (ACRV) Depreciation & Amortization (CF) (2021 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Acrivon Therapeutics reported Depreciation & Amortization (CF) of $1.5 million, up 23.6% year-over-year; for FY2025, it was $1.4 million, up 39.2% from FY2024.
- Depreciation & Amortization (CF) has increased in each of the last four years, with a four-year compound annual growth rate of 148.0% (FY2021 to FY2025).
- Going back by year, Depreciation & Amortization (CF) was $1.01 million in FY2024 (+87.7%), $536,000 in FY2023 (+34.0%), $400,000 in FY2022 (+981.1%) and $37,000 in FY2021.
- Year-over-year, Depreciation & Amortization (CF) has increased for three consecutive quarters, with growth averaging 63.2% over the last eight quarters.
- The fastest year-over-year change in Depreciation & Amortization (CF) over five years came in Q3 2024 (growth of 200.0%), and the weakest in Q4 2023 (a decline of 15.5%).
- Business Quant data shows ACRV's Depreciation & Amortization (CF) at $400,000 (Q1 2026), $400,000 (Q4 2025) and $300,000 (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dep. & Amort. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 534.00 Mn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 1.96 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 194.00 Mn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 599.00 Mn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | 1.93 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 1.11 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | 98.00 Mn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 1.62 Bn |
| 10 | Acrivon Therapeutics | 86.12 Mn | 86.12 Mn | - | 400,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 400,000.00 |
| Mar 31, 2026 | 400,000.00 |
| Dec 31, 2025 | 400,000.00 |
| Sep 30, 2025 | 300,000.00 |
| Jun 30, 2025 | 300,000.00 |
| Mar 31, 2025 | 311,000.00 |
| Dec 31, 2024 | 303,000.00 |
| Sep 30, 2024 | 300,000.00 |
| Jun 30, 2024 | 200,000.00 |
| Mar 31, 2024 | 224,000.00 |
| Dec 31, 2023 | 136,000.00 |
| Sep 30, 2023 | 100,000.00 |
| Jun 30, 2023 | 100,000.00 |
| Mar 31, 2023 | 125,000.00 |
| Dec 31, 2022 | 161,000.00 |
| Sep 30, 2022 | 100,000.00 |
| Jun 30, 2022 | 100,000.00 |
| Mar 31, 2022 | 45,000.00 |
| Dec 31, 2021 | 13,000.00 |
| Sep 30, 2021 | 9,000.00 |
API Access
Acrivon Therapeutics Depreciation & Amortization (CF) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=ACRV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "depreciation-and-amortization-cf", "ticker": "ACRV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=ACRV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();